Innovator Ibd 50 Etf Performance
| FFTY Etf | USD 34.36 0.01 0.03% |
The etf retains a Market Volatility (i.e., Beta) of -0.59, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Innovator IBD are expected to decrease at a much lower rate. During the bear market, Innovator IBD is likely to outperform the market.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator IBD 50 are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Innovator IBD showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| In Threey Sharp Ratio | 0.23 |
Innovator | Build AI portfolio with Innovator Etf |
Innovator IBD Relative Risk vs. Return Landscape
If you would invest 3,005 in Innovator IBD 50 on May 28, 2025 and sell it today you would earn a total of 431.00 from holding Innovator IBD 50 or generate 14.34% return on investment over 90 days. Innovator IBD 50 is currently generating 0.2255% in daily expected returns and assumes 1.5966% risk (volatility on return distribution) over the 90 days horizon. In different words, 14% of etfs are less volatile than Innovator, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Innovator IBD Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovator IBD's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Innovator IBD 50, and traders can use it to determine the average amount a Innovator IBD's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1413
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FFTY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.6 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Innovator IBD is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innovator IBD by adding it to a well-diversified portfolio.
Innovator IBD Fundamentals Growth
Innovator Etf prices reflect investors' perceptions of the future prospects and financial health of Innovator IBD, and Innovator IBD fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Innovator Etf performance.
| Price To Earning | 24.64 X | |||
| Price To Book | 3.76 X | |||
| Price To Sales | 3.74 X | |||
| Total Asset | 97.73 M | |||
About Innovator IBD Performance
Evaluating Innovator IBD's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Innovator IBD has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Innovator IBD has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund will normally invest at least 80 percent of its net assets in securities that comprise the index. Innovator Ibd is traded on NYSEARCA Exchange in the United States.| The fund created five year return of -1.0% | |
| Innovator IBD 50 retains 99.92% of its assets under management (AUM) in equities |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Innovator IBD 50. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator IBD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.